OverviewSuggest Edit

brtxDISC (DiscImplantedStemCells) is an investigational non-surgical treatment for bulging and herniated lumbar discs that is intended for patients who have failed non-invasive procedures and face the prospect of surgery. The treatment involves culturing a patient's own stem cells and then delivering them via a proprietary medical device to the damaged region of the disc in an outpatient procedure. ThermoStem is a treatment using brown fat stem cells that is under development for metabolic disorders including diabetes and obesity. Initial preclinical research indicates that increased amounts of brown fat in the body may be responsible for additional caloric burning as well as reduced glucose and lipid levels. brtx-C Cosmetic is based on the development of a human cellular extract that has been demonstrated in in vitro skin studies to increase the production of collagen and fibronectin, which are proteins that are essential to combating the aging of skin. Potential cosmetic uses are being explored with third parties.
TypePublic
Founded1997
HQMelville, US
Websitebiorestorative.com

Latest Updates

Employees (est.) (Dec 2018)8(-11%)
Revenue (FY, 2018)$111 K(+38%)

Key People/Management at BioRestorative Therapies

Mark R. Weinreb

Mark R. Weinreb

Chief Executive Officer, President, and Chairman
Mandy D. Clyde

Mandy D. Clyde

Vice President of Operations and Corporate Secretary
Francisco Silva

Francisco Silva

Vice President of Research and Development and Chief Scientist
Robert Paccasassi

Robert Paccasassi

Vice President, Quality and Compliance
Adam Bergstein

Adam Bergstein

Senior Vice President, Planning and Business Development
Show more

BioRestorative Therapies Office Locations

BioRestorative Therapies has an office in Melville
Melville, US (HQ)
40 Marcus Dr
Show all (1)

BioRestorative Therapies Financials and Metrics

BioRestorative Therapies Revenue

BioRestorative Therapies's revenue was reported to be $111 k in FY, 2018
USD

Revenue (Q2, 2019)

31.0k

Net income (Q2, 2019)

(4.2m)

EBIT (Q2, 2019)

(2.1m)

Market capitalization (8-Oct-2018)

10.4m

Cash (30-Jun-2019)

1.3m
BioRestorative Therapies's current market capitalization is $10.4 m.
Annual
USDFY, 2013FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Revenue

1.7k1.7k416.0k628.9k36.4k81.0k111.0k

Revenue growth, %

24662%51%(94%)

Cost of goods sold

208.0208.0213.8k261.5k102.0

Gross profit

1.5k1.5k202.2k367.4k36.3k
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019

Revenue

125.0375.0175.9k159.9k184.9k148.8k96.1k9.1k16.2k5.0k7.0k20.0k16.0k19.0k37.0k26.0k29.0k31.0k

Cost of goods sold

10.060.042.4k66.1k76.4k74.6k50.9k10.071.0

Gross profit

115.0315.0133.6k93.8k108.5k74.1k45.2k9.1k16.1k

Gross profit Margin, %

92%84%76%59%59%50%47%100%100%
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Cash

201.1k91.8k166.6k31.8k451.7k117.5k

Accounts Receivable

93.4k6.0k38.0k29.0k

Inventories

18.0k1.9k29.3k

Current Assets

239.8k114.3k289.3k61.7k519.7k181.0k
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019

Cash

642.0110.4k59.2k374.0k145.9k6.4k12.8k353.1k516.2k6.3k8.9k1.9k734.08.6k3.5k105.4k496.3k1.3m

Accounts Receivable

51.0k9.0k16.0k5.0k7.0k20.0k16.0k19.0k37.0k26.0k29.0k31.0k

Inventories

18.0k17.9k17.8k17.4k1.9k2.5k2.5k19.6k

Current Assets

66.3k137.3k95.0k421.5k180.2k246.1k385.0k384.2k546.2k32.6k38.2k46.6k36.3k44.9k75.6k182.0k647.3k1.4m
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Net Income

(5.8m)(5.6m)(7.9m)(8.6m)(9.4m)(12.5m)

Depreciation and Amortization

104.8k96.7k213.8k258.4k259.3k240.4k

Inventories

(5.5k)613.0(6.8k)

Accounts Payable

498.5k(234.6k)1.4m(113.2k)186.0k(516.1k)
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019

Net Income

(4.1m)(1.7m)(3.0m)(4.1m)(1.8m)(3.2m)(4.8m)(2.5m)(4.7m)(6.6m)(2.8m)(7.6m)(2.5m)(6.0m)(8.9m)(3.9m)(8.0m)

Depreciation and Amortization

79.1k25.5k50.1k73.9k89.5k150.6k62.4k127.2k192.7k64.3k195.2k60.6k121.6k183.1k52.7k105.6k

Inventories

(5.5k)61.0175.0580.01.9k(547.0)(547.0)

Accounts Payable

384.8k(59.4k)(369.0k)(488.4k)1.3m313.4k629.9k(265.1k)(377.2k)(421.9k)15.0k410.0k(68.9k)(177.7k)(342.7k)(289.8k)(457.4k)
USDY, 2019

Financial Leverage

-0.3 x
Show all financial metrics

BioRestorative Therapies Online and Social Media Presence

Embed Graph

BioRestorative Therapies News and Updates

BioRestorative Therapies Comments on Recent Promotional Activity

MELVILLE, N.Y., Sept. 13, 2019 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (the “Company") (OTC: BRTX), a life sciences company focused on stem cell - based therapies, is providing comment on recent promotional activity concerning its shares of common stock traded on the OTCQB market. 

BioRestorative Therapies to Present at the 22nd Annual American Society of Gene and Cell Therapy as to Data on its Platform Technology for the Treatment of Metabolic Disorders

Cell Based Therapy for the Treatment of Type 2 Diabetes, Obesity, Hyperlipidemia and Hypertension Cell Based Therapy for the Treatment of Type 2 Diabetes, Obesity, Hyperlipidemia and Hypertension

BioRestorative Therapies Announces the Creation of a Disc Advisory Committee

Jason Lipetz, MD to Chair Committee Jason Lipetz, MD to Chair Committee

BioRestorative Therapies Receives Notice of Allowance for Key Metabolic Patent in the United States

MELVILLE, N.Y., Nov. 15, 2018 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. ("BioRestorative" or the “Company") (OTC: BRTX), a life sciences company focused on stem cell-based therapies, today announced that the United States Patent and Trademark Office has issued BioRestorative a Notice of A…

BioRestorative Therapies Announces the Appointment of Lance Alstodt as Executive VP and Chief Strategy Officer

MELVILLE, N.Y., Oct. 18, 2018 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. ("BioRestorative" or the “Company") (OTC:BRTX), a life sciences company focused on stem cell-based therapies, today announced the appointment of Lance Alstodt as Executive Vice President and Chief Strategy Officer. In…

BioRestorative Therapies Announces Metabolic Research Collaboration with University of Pennsylvania

MELVILLE, N.Y., Sept. 24, 2018 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. ("BioRestorative" or the “Company") (OTC: BRTX), a life sciences company focused on stem cell-based therapies, today announced that the Company has entered into a one-year material transfer agreement with the Univers…
Show more

BioRestorative Therapies Blogs

ASGCT Presentation April 2019

ASGCT Presentation April 2019

ASGCT Poster April 2019

ASGCT Poster 2019

BRTX-100 Overview

BioRestorative Therapies Appoints Jason S. Lipetz, M.D. to its Scientific Advisory Board

MELVILLE, N.Y., July 25, 2018 — BioRestorative Therapies, Inc. (“BioRestorative” or the “Company”) (OTC: BRTX), a life sciences company focused […]

BioRestorative Therapies Frequently Asked Questions

  • When was BioRestorative Therapies founded?

    BioRestorative Therapies was founded in 1997.

  • Who are BioRestorative Therapies key executives?

    BioRestorative Therapies's key executives are Mark R. Weinreb, Mandy D. Clyde and Francisco Silva.

  • How many employees does BioRestorative Therapies have?

    BioRestorative Therapies has 8 employees.

  • What is BioRestorative Therapies revenue?

    Latest BioRestorative Therapies annual revenue is $111 k.

  • What is BioRestorative Therapies revenue per employee?

    Latest BioRestorative Therapies revenue per employee is $13.9 k.

  • Who are BioRestorative Therapies competitors?

    Competitors of BioRestorative Therapies include Quartesian, Banner Life Sciences and BBK Worldwide.

  • Where is BioRestorative Therapies headquarters?

    BioRestorative Therapies headquarters is located at 40 Marcus Dr, Melville.

  • Where are BioRestorative Therapies offices?

    BioRestorative Therapies has an office in Melville.

  • How many offices does BioRestorative Therapies have?

    BioRestorative Therapies has 1 office.